Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 818937, 11 pages
http://dx.doi.org/10.1155/2012/818937
Research Article

Administration of Bone Marrow Derived Mesenchymal Stem Cells into the Liver: Potential to Rescue Pseudoxanthoma Elasticum in a Mouse Model (Abcc6−/−)

Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, 233 S. 10th Street, Philadelphia, PA 19107, USA

Received 13 July 2012; Accepted 20 September 2012

Academic Editor: Ken-ichi Isobe

Copyright © 2012 Qiujie Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Li, Q. Jiang, E. Pfendner, A. Váradi, and J. Uitto, “Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms,” Experimental Dermatology, vol. 18, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. H. Neldner, “Pseudoxanthoma elasticum,” Clinics in dermatology, vol. 6, no. 1, pp. 1–159, 1988. View at Google Scholar · View at Scopus
  3. F. Ringpfeil, M. G. Lebwohl, A. M. Christiano, and J. Uitto, “Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 6001–6006, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. A. A. B. Bergen, A. S. Plomp, E. J. Schuurman et al., “Mutations in ABCC6 cause pseudoxanthoma elasticum,” Nature Genetics, vol. 25, no. 2, pp. 228–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Matsuzaki, A. Nakano, Q. J. Jiang, L. Pulkkinen, and J. Uitto, “Tissue-specific expression of the ABCC6 gene,” Journal of Investigative Dermatology, vol. 125, no. 5, pp. 900–905, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. F. Klement, Y. Matsuzaki, Q. J. Jiang et al., “Targeted ablation of the Abcc6 gene results in ectopic mineralization of connective tissues,” Molecular and Cellular Biology, vol. 25, no. 18, pp. 8299–8310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Jiang, M. Endo, F. Dibra, K. Wang, and J. Uitto, “Pseudoxanthoma elasticum is a metabolic disease,” Journal of Investigative Dermatology, vol. 129, no. 2, pp. 348–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Jiang, R. Oldenburg, S. Otsuru, A. E. Grand-Pierre, E. M. Horwitz, and J. Uitto, “Parabiotic heterogenetic pairing of Abcc6−/−/Rag1−/− mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum,” American Journal of Pathology, vol. 176, no. 4, pp. 1855–1862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. W. Culver and K. W. Culver, “Measuring success in clinical gene therapy research,” Molecular Medicine Today, vol. 2, no. 6, pp. 234–236, 1996. View at Google Scholar · View at Scopus
  10. R. Gardlík, R. Pálffy, J. Hodosy, J. Lukács, J. Turňa, and P. Celec, “Vectors and delivery systems in gene therapy,” Medical Science Monitor, vol. 11, no. 4, pp. RA110–RA121, 2005. View at Google Scholar · View at Scopus
  11. N. B. Woods, V. Bottero, M. Schmidt, C. Von Kalle, and I. M. Verma, “Gene therapy: therapeutic gene causing lymphoma,” Nature, vol. 440, no. 7088, p. 1123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. T. K. Kuo, S. P. Hung, C. H. Chuang et al., “Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells,” Gastroenterology, vol. 134, no. 7, pp. 2111–e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Lysy, D. Campard, F. Smets, M. Najimi, and E. M. Sokal, “Stem cells for liver tissue repair: current knowledge and perspectives,” World Journal of Gastroenterology, vol. 14, no. 6, pp. 864–875, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ellor, T. Shupe, and B. Petersen, “Stem cell therapy for inherited metabolic disorders of the liver,” Experimental Hematology, vol. 36, no. 6, pp. 716–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. A. Lysy, M. Najimi, X. Stéphenne, A. Bourgois, F. Smets, and E. M. Sokal, “Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives,” World Journal of Gastroenterology, vol. 14, no. 22, pp. 3464–3470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Matas, D. E. R. Sutherland, and M. W. Steffes, “Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats,” Science, vol. 192, no. 4242, pp. 892–894, 1976. View at Google Scholar · View at Scopus
  17. G. M. Higgins and R. M. Anderson, “Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgerical removal,” Archives of Pathology, vol. 12, no. 2, pp. 186–202, 1931. View at Google Scholar
  18. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén, “HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells,” Experimental Hematology, vol. 31, no. 10, pp. 890–896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau, “Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice,” Blood, vol. 106, no. 13, pp. 4057–4065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Ishii, Y. Yoshida, Y. Akechi et al., “Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3β,” Hepatology, vol. 48, no. 2, pp. 597–606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. L. Shi, L. Mao, B. Y. Xu et al., “Optimization of an effective directed differentiation medium for differentiating mouse bone marrow mesenchymal stem cells into hepatocytes in vitro,” Cell Biology International, vol. 32, no. 8, pp. 959–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Abbott, Y. Huang, D. Liu, R. Hickey, D. S. Krause, and F. J. Giordano, “Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury,” Circulation, vol. 110, no. 21, pp. 3300–3305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Karp and G. S. Leng Teo, “Mesenchymal stem cell homing: the devil is in the details,” Cell Stem Cell, vol. 4, no. 3, pp. 206–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Cheng, L. Ou, X. Zhou et al., “Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance,” Molecular Therapy, vol. 16, no. 3, pp. 571–579, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Aurich, L. P. Mueller, H. Aurich et al., “Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers,” Gut, vol. 56, no. 3, pp. 405–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kadereit and A. Trounson, “In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages,” Seminars in Immunopathology, vol. 33, no. 6, pp. 551–562, 2011. View at Publisher · View at Google Scholar · View at Scopus